Many congratulations to Aria Mingo, an undergraduate student at Cornell University. Aria is the first person to have applied for funding through our web form, and was seeking ~$250 to fill in a funding gap, and allow her to travel to the Annual Biomedical Research Conference for Minoritized Scientists (ABRCMS), to present her work in a poster titled “Human Milk Oligosaccharides Ameliorate Nosocomial Infections as Protective Coatings”. Helping students to advance their careers as scientists is one of our top priorities as a local section, and while our funding is limited, we’re absolutely delighted to have been able to assist Aria in sharing her work.
Abstract: Increasing rates of morbidity and mortality within hospitals are caused by pathogenic bacteria colonizing indwelling medical devices. This abiotic surface adherence is caused by the ability of bacteria to form biofilms. Bacterial biofilms are three-dimensional communities of microorganisms surrounded by a self produced extracellular polymeric matrix. Bacterial biofilms confer increased resistance to antibiotics, resulting in invasive infections among immunocompromised patients. Human milk oligosaccharides (HMOs), the carbohydrate component of human breast milk, are known to promote growth of commensal bacteria while inhibiting the growth of pathogenic bacteria in the infant gut. Recent studies have shown that outside the neonate, HMOs have both antibacterial and biofilm-inhibiting properties. With this in mind, we employed HMOs as anti-adhesive coatings against various pathogens to assess abiotic bacterial adherence to various materials. HMOs were used to reduce bacterial adhesion on surfaces imitating those most commonly populated by nosocomial pathogens, including catheters, prostheses and pacemakers, among others. The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species) exhibit high antibiotic resistance and are responsible for 15.5% of hospital-acquired infections. Plastic surfaces (24-well plate base) and glass surfaces (glass coverslip) were exposed to HMOs for 12 hours. After the solution evaporated, bacterial cells were added to the surfaces and incubated. The next day, bacterial density (OD600) and biofilm formation (OD560) were spectrophotometrically determined. While HMO treatment did not elicit any changes in bacterial density, significant decreases in bacterial adherence were observed across strains assessed in this study. The results indicate that the addition of HMOs reduces the adherence of both gram-negative and gram-positive bacteria on both plastic and glass surfaces. This research highlights the potential for HMOs as protective coatings on indwelling medical devices to mitigate the spread of hospital-acquired infections.